NKTP

NÖK Therapeutics, Inc. Stock Price

OTCPK:NKTP Community·n/a Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NKTP Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

NKTP Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

NÖK Therapeutics, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About NKTP

Founded
2024
Employees
n/a
CEO
Robert Lewis
WebsiteView website
www.noktx.com

NÖK Therapeutics, Inc. operates as a biotechnology company that develops autologous natural killer (NK) cell therapies. It provides cell therapies, bispecific antibodies, checkpoint inhibitors, severe toxicity profiles, autologous, non-engineered, lymphodepletion, dosing and outpatient infusions. The company was incorporated in 2024 and is based in Cranberry Township, Pennsylvania.

Recent NKTP News & Updates

No updates

Recent updates

No updates